About AVID TRADEX
AVID TRADEX is a company based in Nagpur (India) founded in 2019. It operates as a B2B and Exporting. AVID TRADEX offers products and services including Pharmaceutical Tablets, Pharma Tablets, Female Healthcare Products, Pharmaceutical Capsules, and HIV AIDS Medicines. AVID TRADEX operates in a competitive market with competitors including Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma, among others.
- Headquarter Nagpur, India
- SectorsHealthcare
- Phone•••• ••••
- Website avidtradex.com
- Legal Name Avid Tradex Private Limited
- Date of Incorporation 03 Apr, 2019
- Jurisdiction Ramdaspeth, Maharashtra, India
- Annual Revenue₹1.20 Cr
FY 2022 · +143% YoY
- Net Profit₹1.5 Lakh
FY 2022 · 1% margin
- EBITDA₹2.2 Lakh
FY 2022 · 2% margin
Associated legal entities of AVID TRADEX
AVID TRADEX operates through Avid Tradex Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avid Tradex Private Limited CIN U51909MH2019PTC323616 | Active | 03 Apr 2019 | Ramdaspeth, Maharashtra | ₹1.2 Cr | – | 2 | View details |
Products & Services of AVID TRADEX
AVID TRADEX offers a comprehensive portfolio of products and services, including Pharmaceutical Tablets, Pharma Tablets, Female Healthcare Products, Pharmaceutical Capsules, and HIV AIDS Medicines.
Tablets for treating various health conditions.
Specialty tablets including anti-cancer options.
Products for women's health needs.
Capsules for HIV and other treatments.
Medicines for managing HIV conditions.
Tablets for treating erectile dysfunction.
Board of directors of Avid Tradex Private Limited (AVID TRADEX)
Avid Tradex Private Limited is the primary company behind AVID TRADEX. The board of Avid Tradex Private Limited currently have 2 directors; the longest-serving is Apoorv Chopde, appointed in 2019. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Apoorv Chopde DIN 08411300 | Director | 03 Apr 2019 | 7 yrs 6 mo | Avid Tradex Private Limited |
| Akshay Manoj Dalvi DIN 07722868 | Director | 18 Feb 2020 | 6 yrs 7 mo | Avid Tradex Private Limited |
Financials of AVID TRADEX
Figures of Avid Tradex Private Limited, the primary company behind AVID TRADEX, for FY 2022. Revenue was ₹1.20 Cr (+143% year on year). Net profit was ₹1.5 Lakh (1% margin). EBITDA was ₹2.2 Lakh (2% margin).
- ₹1.20 CrRevenue · FY 2022 · +143% YoY
- ₹1.5 LakhNet profit · 1% margin
- ₹2.2 LakhEBITDA · 2% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Avid Tradex Private Limited are on its company page.
Detailed financial statements for AVID TRADEX
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of AVID TRADEX
AVID TRADEX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, ACG Associated Capsules, Dvijay Pharma, Nu Sri Shyam Pharmaceuticals and Kapbro Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardinalhealth.com | 1971 | Dublin, United States | – | 48,900 | Multiple healthcare products and services are provided to organizations. | |
| associatedcapsules.com | 1961 | Mumbai, India | – | 1,444 | A distributor specializing in gelatin capsules for pharmaceutical applications. | |
| dvijaypharma.com | 1975 | Nashik, India | – | 68 | Serves as a distributor of specialty drugs. | |
| nsspharma.com | 2013 | Kolkata, India | – | 58 | Distributes anti-HIV, life-saving, and anti-cancer medicines to hospitals and patients. | |
| kapbropharma.com | 2018 | Delhi, India | – | 26 | Distributes super-speciality and general pharmaceuticals to chemists, hospitals, and patients. | |
| shivshivampharma.com | 1989 | Kolkata, India | – | 18 | Distributor and retailer of oncology medicines with partnerships in healthcare. | |
| shreejiimaging.com | 1990 | Mumbai, India | – | – | Manufactures PET radiotracers for cancer detection and disease management. |
Detailed competitors of AVID TRADEX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to AVID TRADEX
10 companies that operate in the same segment as AVID TRADEX (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AVID TRADEX
AVID TRADEX was founded in 2019.
AVID TRADEX is headquartered in Nagpur, India. It is registered at Nagpur, Maharashtra, India.
The primary company behind AVID TRADEX, Avid Tradex Private Limited, reported revenue of ₹1.20 Cr for FY 2022, up 143% year on year.
Avid Tradex Private Limited operates as a wholesale trader and exporter of pharmaceutical products, including tablets, capsules, and specialty medicines like anti-cancer and HIV treatments. They source and distribute these items to businesses in India and potentially internationally. Based in Nagpur, Maharashtra, the company focuses on serving healthcare needs through efficient trading practices, maintaining a range of products for various health conditions.
AVID TRADEX's top competitors include Cardinal Health, Dvijay Pharma and ACG Associated Capsules.
AVID TRADEX offers Pharmaceutical Tablets, Pharma Tablets, Female Healthcare Products, Pharmaceutical Capsules, and 2 more products and services.
AVID TRADEX operates through Avid Tradex Private Limited.
The legal entities of AVID TRADEX currently have 2 directors, including Akshay Manoj Dalvi, Apoorv Chopde.